Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqtechno1
    Member
    • May 2017
    • 21

    #1

    pacbio sequel system

    how much do core facilities charge to run the instrument, not per sample or SMRTcell but just to recover the cost of running the device? (electricity, nitrogen, etc.)
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    This is a rare case and I do not think that someone would have any readily available figures. It seems that you want to place your machine in a core lab and operate it yourself. The cost will depend on if you are going to use other facilities such as bench space and lab equipment. I would consider paying space rent and associated costs such as security, electricity, Nitrogen gas, IT infrastructure for transferring and/or storing data (sort of fixed expenses), insurance, lab mishapps and damage due to your system malfunction to their facility (might be covered by your insurance). You also have to work out compensation scheme if your machine is damaged due to a accident or negligence form their staff.

    Comment

    • SNPsaurus
      Registered Vendor
      • May 2013
      • 525

      #3
      Most core facilities are subsidized by the university and do not need to develop a full cost accounting for the operation of their equipment. They look at prevailing rates, charge something similar, and hope the Research Office covers any loss. I'm curious what is motivating your question?
      Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Since those costs will vary from place to place even if you managed to get facilities to divulge that information it may not be of use.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...